AB INVESTOR
CIK 889232 · last filed 2026-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.69B
Companies
7
Total Filings
29
Lifetime Open-Market Net
$81.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NDAQ | 10%+ Owner | 58,382,426 | $97.54 | $5.69B | $92.85M | 8 | 2026-02-13 |
| GREENWAY MEDICAL TECHNOLOGIES INC (GWAY) Delisted | 10%+ Owner | 0 | — | — | $0 | 2 | 2013-11-05 |
| Mattersight Corp (MATR) Delisted | 0 | — | — | $0 | 1 | 2012-05-10 | |
| TANGOE INC (TNGO) Delisted | 2,760,943 | — | — | -$1.23M | 1 | 2011-08-02 | |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 3,804,224 | — | — | -$8.10M | 2 | 2009-12-30 |
| ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | 10%+ Owner | 288,807 | $76.01 | $21.95M | $1.37M | 4 | 2008-12-22 |
| ISTA PHARMACEUTICALS INC (ISTA) Delisted | 10%+ Owner | 1,860,874 | — | — | -$3.39M | 11 | 2007-06-19 |
Recent Filings · Page 2 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-08-04 | NDAQ | Buy (P) | +800,000 | $18.62M | EDGAR |
| 2011-08-02 | TANGOE INC (TNGO) Delisted | Sell (S) | −132,361 | -$1.23M | EDGAR |
| 2009-12-30 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Sell (S) | −503,016 | -$1.59M | EDGAR |
| 2009-12-18 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Sell (S) | −1,953,980 | -$6.51M | EDGAR |
| 2008-12-22 | ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | Buy (P) | +935,000 | $892.5K | EDGAR |
| 2008-12-10 | ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | Buy (P) | +255,000 | $255.8K | EDGAR |
| 2008-12-08 | ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | Buy (P) | +200,000 | $200.8K | EDGAR |
| 2008-12-01 | ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | Buy (P) | +24,700 | $24.7K | EDGAR |
| 2007-06-19 | ISTA PHARMACEUTICALS INC (ISTA) Delisted | Sell (S) | −13,611 | -$110.3K | EDGAR |
| 2007-06-04 | ISTA PHARMACEUTICALS INC (ISTA) Delisted | Sell (S) | −21,231 | -$173.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.